Stock XLO XILIO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Real-time Estimate Cboe BZX
Other stock markets
 03:30:01 2024-05-28 pm EDT 		5-day change 1st Jan Change
0.908 USD -13.52% Intraday chart for Xilio Therapeutics, Inc. -24.08% +65.64%
May. 14 Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 19 Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
XILIO THERAPEUTICS, INC. Stock Xilio Therapeutics, Inc.
 38.75M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 63.85B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.83B
LONZA GROUP AG Stock Lonza Group AG
 40.47B
CELLTRION, INC. Stock Celltrion, Inc.
 27.17B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.52B
  1. Stock Market
  2. Equities
  3. XLO Stock
  4. Charts Xilio Therapeutics, Inc.
  5. Sector Chart